SITC Biotech Strategic Initiative Co-Chair Kristen Hege on the IO field
- blonca9
- Nov 3, 2023
- 1 min read
Dr. Hege discusses the latest in cell therapy, new modalities, and a biotech initiative that SITC is launching.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.